文献速递主动脉疾病

腹主动脉瘤腔内修复术后远期再干预的系统综述与荟萃分析

A systematic review and meta-analysis of long-term reintervention after endovascular abdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2020-04-06

该系统综述与荟萃分析纳入30项研究、32126例EVAR患者,评估术后各年份免于再干预的概率:5年81%、10年70%、14年64%。按器械植入年份分层后,再干预率随新技术应用而改善,提示EVAR患者需终身监测。

要点

  • EVAR术后免于再干预概率5年为81%、10年为70%、14年为64%,远期再干预风险持续存在。
  • 按植入年份分层,3年免于再干预从1998年77%升至2008年90%(P=.006),7年从1998年51%升至2011年86%(P=.015)。
  • 再干预率仍是评价新器械与注册登记数据的重要指标,EVAR术后应终身监测。

核心结论

  • EVAR患者终身存在再干预风险,因此必须终身监测。
  • 随器械技术更新,再干预率随时间改善,新器械再干预率更低。
  • 再干预率仍是新器械和注册登记研究的重要评价指标。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase、Cochrane Library和ClinicalTrials.gov,遵循PRISMA指南。
  • 纳入随机对照试验3项和观察性研究27项,共30项研究、32126例患者。
  • 器械植入日期跨度为1996年至2014年,对每一年术后免于再干预的Kaplan-Meier数据进行荟萃分析。
  • 采用线性回归评估随器械技术更新再干预率随时间的变化。

主要发现

  • 免于再干预概率5年为81%(95%CI 77%-85%),10年为70%(95%CI 65%-76%),14年为64%(95%CI 46%-79%)。
  • 1年免于再干预从1998年90%升至2008年94%(n=26项研究;R2=0.11;P=.10)。
  • 3年免于再干预从1998年77%升至2008年90%(n=26项研究;R2=0.27;P=.006)。
  • 5年免于再干预从1998年68%升至2008年81%(n=22项研究;R2=0.12;P=.12)。
  • 7年免于再干预从1998年51%升至2011年86%(n=22项研究;R2=0.40;P=.015)。

关键数值与推荐

  • 纳入标准为记录EVAR术后再干预率的随机对照试验和观察性研究。
  • 按器械植入年份分层的线性回归显示免于再干预随时间改善,其中3年(P=.006)和7年(P=.015)达统计学显著。

临床怎么用

  • 应向EVAR术后患者强调终身随访监测的必要性,不可因术后早期稳定而放松。
  • 评估新器械性能与注册登记质量时,可将远期再干预率作为核心指标之一。
  • 咨询再干预风险时可引用5年81%、10年70%、14年64%的免于再干预数据。

局限性

  • 纳入研究以观察性研究为主(27/30),随机对照试验仅3项。
  • 器械植入年份跨度大(1996-2014),不同年代器械与随访方案存在异质性。
  • 1年和5年随植入年份改善的线性回归未达统计学显著(P分别为.10和.12)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients who undergo endovascular aneurysm repair (EVAR) often require reintervention after the index repair. The long-term rate of reintervention and how this has changed with newer device technology are poorly understood. Therefore, we performed a systematic review and meta-analysis of the available literature to determine long-term freedom from reintervention after EVAR and the change in reintervention rates over time. METHODS: We performed a systematic review of MEDLINE, Embase, Cochrane Library, and ClinicalTrials.gov in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We included randomized controlled trials and observational studies that documented the rate of reintervention after EVAR. We performed a meta-analysis of Kaplan-Meier freedom from reintervention at each year after EVAR. We used linear regression to evaluate change in reintervention rate over time with newer device technology. RESULTS: We included a total of 30 studies (randomized trials, n = 3; observational studies, n = 27) comprising 32,126 patients in this review and meta-analysis. Studies ranged in the implantation date of the EVAR device from 1996 to 2014. The probability of freedom from reintervention was 81% (95% confidence interval [CI], 77%-85%) at 5 years, 70% (95% CI, 65%-76%) at 10 years, and 64% (95% CI, 46%-79%) at 14 years. Linear regression demonstrated an improvement in freedom from reintervention when results were stratified by the year of device implantation. At 1 year, estimated freedom from reintervention improved from 90% in 1998 to 94% in 2008 (n = 26 studies; R2 = 0.11; P = .10). At three years, estimated freedom from reintervention improved from 77% in 1998 to 90% in 2008 (n = 26 studies; R2 = 0.27; P = .006). At 5 years, estimated freedom from reintervention improved from 68% in 1998 to 81% in 2008 (n = 22 studies; R2 =0.12; P = .12). At 7 years, estimated freedom from reintervention improved from 51% in 1998 to 86% in 2011 (n = 22 studies; R2 = 0.40; P = .015). CONCLUSIONS: EVAR patients remain at risk for reintervention indefinitely, and therefore lifelong surveillance is imperative. Encouragingly, reintervention rates have improved over time, with newer devices exhibiting lower rates. Reintervention rate remains an important metric for new devices and registries.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wanken ZJ, Barnes JA, Trooboff SW, et al. A systematic review and meta-analysis of long-term reintervention after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2020. PMID: 32273226. doi:10.1016/j.jvs.2020.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。